Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
No Free TRIPS Act This bill prohibits the U.S. government from negotiating or concluding any withdrawal from or modification to the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) without explicit authorization from Congress. The TRIPS Agreement is one of several international agreements that led to the creation of the World Trade Organization (WTO). In October 2020, in response to the COVID-19 pandemic, several WTO members proposed a waiver of some TRIPS obligations, including obligations related to national patent laws.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2022 · fourth_quarter · Copyright/Patent/Trademark
H.R. 4521, United States Innovation and Competition Act of 2021 H.R. 5376, Inflation Reduction Act of 2022 H.R. 5429, Save our Stages Extension Act H.R. 5502/S. 936, Integrity, Notification, and Fairness in Online Retail Marketplaces for (INFORM) Consumers Act H.R. 7430, Protecting American Innovation Act H.R. 7582/S. 4063, No Free TRIPS Act H.R. 7776, James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 S. 1260, United States Innovation and Competition Act of 2021, including provisions related to research funding and cybersecurity S. 1428, Preserve Access to Affordable Generics and Biosimilars Act S. 1435, Affordable Prescriptions for Patients Act of 2021 S. 1843, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2021 Fiscal Year 2022 Financial Services and General Government Appropriations bill, including provisions related to funding for the Office of Intellectual Property Enforcement Coordinator and other federal agencies appropriations related to intellectual property enforcement Draft legislation titled Digital Copyright Act of 2021 (discussion draft) Potential legislation similar to H.R. 6058, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2020 Potential legislation similar to S. 1416, Affordable Prescriptions for Patients Act of 2019 Potential legislation revising the Family Entertainment and Copyright Act of 2005 Potential legislation making omnibus year-end appropriations Nomination of Chris Wilson to be Chief Intellectual Property Negotiator for the Office of the U.S. Trade Representative Notice, Patent Subject Matter Eligibility Guidance, U.S. Patent and Trademark Office (87 Fed. Reg. 53,736-53,737, September 1, 2022) Request for Comment, Office of the United States Trade Representative; 2022 Review of Notorious Markets for Counterfeiting and Piracy (87 Fed. Reg. 52,609-52,611, August 26, 2022) Various issues relating to implementation of Trade Facilitation and Trade Enforcement Act of 2015 (P.L. 114-125); nomination vacancies relating to intellectual property, including for an Intellectual Property Enforcement Coordinator (IPEC); Office of the Intellectual Property Enforcement Coordinator and the National Intellectual Property Rights Coordination Center; the U.S. Patent and Trademark Office; World Trade Organization pending proposal related to COVID-19 and intellectual property rights; State Department Office of Authentication; IP issues related to Australia, Canada, China, India, Brazil, Europe, Mexico and South Africa; IP issues related to internet counterfeiting and piracy; patent linkage and regulatory data protection; the World Intellectual Property Organization; the World Trade Organization; the World Health Organization; the International Telecommunications Union; IP issues related to prescription drug pricing and labeling; modernization of the U.S. Copyright Office; increased utilization of federal criminal penalties resulting from the passage of the Protect Lawful Streaming Act (PSLA) (P.L. 116-260, Div. Q, Title II), for certain types of copyright infringement via illicit streaming of copyrighted works; intellectual property enforcement priorities at the U.S.-Mexico border; licensing negotiations and remedies for standard-essential patents subject to voluntary F/RAND commitments; third party litigation funding and patent litigation
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $20,990,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
2022 · third_quarter · Copyright/Patent/Trademark
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, including provisions related to price controls and prescription drugs H.R. 4521, United States Innovation and Competition Act of 2021 H.R. 5376, Inflation Reduction Act of 2022 H.R. 5429, Save our Stages Extension Act H.R. 5502/S. 936, Integrity, Notification, and Fairness in Online Retail Marketplaces for (INFORM) Consumers Act H.R. 7430, Protecting American Innovation Act H.R. 7582/S. 4063, No Free TRIPS Act S. 1260, United States Innovation and Competition Act of 2021, including provisions related to research funding and cybersecurity S. 1428, Preserve Access to Affordable Generics and Biosimilars Act S. 1435, Affordable Prescriptions for Patients Act of 2021 S. 1843, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2021 Fiscal Year 2022 Financial Services and General Government Appropriations bill, including provisions related to funding for the Office of Intellectual Property Enforcement Coordinator and other federal agencies appropriations related to intellectual property enforcement Draft legislation titled Digital Copyright Act of 2021 (discussion draft) Potential legislation similar to H.R. 6058, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2020 Potential legislation similar to S. 1416, Affordable Prescriptions for Patients Act of 2019 Potential legislation revising the Family Entertainment and Copyright Act of 2005 Nomination of Chris Wilson to be Chief Intellectual Property Negotiator for the Office of the U.S. Trade Representative Various issues relating to implementation of Trade Facilitation and Trade Enforcement Act of 2015 (P.L. 114-125); nomination vacancies relating to intellectual property, including for an Intellectual Property Enforcement Coordinator (IPEC); Office of the Intellectual Property Enforcement Coordinator and the National Intellectual Property Rights Coordination Center; the U.S. Patent and Trademark Office; World Trade Organization pending proposal related to COVID-19 and intellectual property rights; State Department Office of Authentication; IP issues related to Australia, Canada, China, India, Brazil, Europe, Mexico and South Africa; IP issues related to internet counterfeiting and piracy; patent linkage and regulatory data protection; the World Intellectual Property Organization; the World Trade Organization; the World Health Organization; the International Telecommunications Union; IP issues related to the U.S.-Mexico, Canada Agreement (USMCA); IP issues related to prescription drug pricing and labeling; modernization of the U.S. Copyright Office; increased utilization of federal criminal penalties resulting from the passage of the Protect Lawful Streaming Act (PSLA) (P.L. 116-260, Div. Q, Title II), for certain types of copyright infringement via illicit streaming of copyrighted works; intellectual property enforcement priorities at the U.S.-Mexico border licensing negotiations and remedies for standard-essential patents subject to voluntary F/RAND commitments
Client expense: $23,940,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
2022 · second_quarter · Copyright/Patent/Trademark
S 4063 "No FREE Trips Act," all provisions. S 4417 "Patent Trial and Apeal Board Reform Act of 2022," all provisions.
Client expense: $110,000 · Firm income: Not reported
Government targets: SENATE
2022 · second_quarter · Copyright/Patent/Trademark
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, including provisions related to price controls and prescription drugs H.R. 5502/S. 936, Integrity, Notification, and Fairness in Online Retail Marketplaces for (INFORM) Consumers Act H.R. 7430, Protecting American Innovation Act H.R. 7582/S. 4063, No Free TRIPS Act S. 1260, United States Innovation and Competition Act of 2021, including provisions related to research funding and cybersecurity S. 1428, Preserve Access to Affordable Generics and Biosimilars Act S. 1435, Affordable Prescriptions for Patients Act of 2021 S. 1843, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2021 Fiscal Year 2022 Financial Services and General Government Appropriations bill, including provisions related to funding for the Office of Intellectual Property Enforcement Coordinator and other federal agencies appropriations related to intellectual property enforcement Draft legislation titled Digital Copyright Act of 2021 (discussion draft) Potential legislation similar to H.R. 6058, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2020 Potential legislation similar to S. 1416, Affordable Prescriptions for Patients Act of 2019 Potential legislation revising the Family Entertainment and Copyright Act of 2005 Nomination of Chris Wilson to be Chief Intellectual Property Negotiator for the Office of the U.S. Trade Representative Nomination of Katherine Vidal to be Director of the U.S. Patent and Trademark Office (USPTO) Request for Information, Department of Agriculture; Regarding Competition and the Intellectual Property System: Seeds and Other Agricultural Inputs (87 Fed. Reg. 29,730, March 17, 2022) Various issues relating to implementation of Trade Facilitation and Trade Enforcement Act of 2015 (P.L. 114-125); nomination vacancies relating to intellectual property, including for an Intellectual Property Enforcement Coordinator (IPEC); Office of the Intellectual Property Enforcement Coordinator and the National Intellectual Property Rights Coordination Center; the U.S. Patent and Trademark Office; World Trade Organization pending proposal related to COVID-19 and intellectual property rights; State Department Office of Authentication; IP issues related to Australia, Canada, China, India, Brazil, Europe, Mexico and South Africa; IP issues related to internet counterfeiting and piracy; patent linkage and regulatory data protection; the World Intellectual Property Organization; the World Trade Organization; the World Health Organization; the International Telecommunications Union; IP issues related to the U.S.-Mexico, Canada Agreement (USMCA); IP issues related to prescription drug pricing and labeling; modernization of the U.S. Copyright Office; increased utilization of federal criminal penalties resulting from the passage of the Protect Lawful Streaming Act (PSLA) (P.L. 116-260, Div. Q, Title II), for certain types of copyright infringement via illicit streaming of copyrighted works; intellectual property enforcement priorities at the U.S.-Mexico border; licensing negotiations and remedies for standard-essential patents subject to voluntary F/RAND commitments
Client expense: $15,800,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
2022 · second_quarter · Copyright/Patent/Trademark
S 4063 "No FREE Trips Act," all provisions. S 4417 "Patent Trial and Apeal Board Reform Act of 2022," all provisions.
Client expense: $110,000 · Firm income: Not reported
Government targets: SENATE
2021 · first_quarter · Disaster Planning/Emergencies
Specific Lobbying Issues: 1031 Like Kind Exemption Coalition - U.S. House and Senate American Rescue Act Covid Provisions/RIDEA - U.S. House and Senate HHS Provider Fund relief - U.S. House, Senate, Health and Human Services Health Real Estate Investment Trusts (REIT) provisions - U.S. House COVID-19 provisions - White House Bills: H.R.748 - Coronavirus Aid, Relief, and Economic (CARES) Act H.R.335 - American Rescue Plan H.R.6351 - Universal Coronavirus Vaccine Act S.3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.1319 - American Rescue Plan Act of 2021 H.R. 8805 - Retail Revitalization Act of 2020 H.R. 840 - Retail Revitalization Act of 2021 S. 234 (IS) - Americans Giving Care to Elders (AGE) Act of 2021 H.R. 8472 - Impact Aid Coronavirus Relief Act H.R.8075 - Impact Aid Coronavirus Relief Act S.4063 - Impact Aid Coronavirus Relief Act H.R.6800 - The HEROES Act S. 4800 - The HEROES Act H.R.133 - Consolidated Appropriations Act, 2021 H.R.8319 - Continuing Appropriations Act, 2021 H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act S.3370 - Coronavirus Vaccine Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2021 · first_quarter · Taxation/Internal Revenue Code
Specific Lobbying Issues: 1031 Like Kind Exemption Coalition - U.S. House and Senate American Rescue Act Covid Provisions/RIDEA - U.S. House and Senate HHS Provider Fund relief - U.S. House, Senate, Health and Human Services Health Real Estate Investment Trusts (REIT) provisions - U.S. House COVID-19 provisions - White House Bills: H.R.748 - Coronavirus Aid, Relief, and Economic (CARES) Act H.R.335 - American Rescue Plan H.R.6351 - Universal Coronavirus Vaccine Act S.3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.1319 - American Rescue Plan Act of 2021 H.R. 8805 - Retail Revitalization Act of 2020 H.R. 840 - Retail Revitalization Act of 2021 S. 234 (IS) - Americans Giving Care to Elders (AGE) Act of 2021 H.R. 8472 - Impact Aid Coronavirus Relief Act H.R.8075 - Impact Aid Coronavirus Relief Act S.4063 - Impact Aid Coronavirus Relief Act H.R.6800 - The HEROES Act S. 4800 - The HEROES Act H.R.133 - Consolidated Appropriations Act, 2021 H.R.8319 - Continuing Appropriations Act, 2021 H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act S.3370 - Coronavirus Vaccine Act
Client expense: Not reported · Firm income: $30,000
2021 · first_quarter · Medical/Disease Research/Clinical Labs
Specific Lobbying Issues: 1031 Like Kind Exemption Coalition - U.S. House and Senate American Rescue Act Covid Provisions/RIDEA - U.S. House and Senate HHS Provider Fund relief - U.S. House, Senate, Health and Human Services Health Real Estate Investment Trusts (REIT) provisions - U.S. House COVID-19 provisions - White House Bills: H.R.748 - Coronavirus Aid, Relief, and Economic (CARES) Act H.R.335 - American Rescue Plan H.R.6351 - Universal Coronavirus Vaccine Act S.3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.1319 - American Rescue Plan Act of 2021 H.R. 8805 - Retail Revitalization Act of 2020 H.R. 840 - Retail Revitalization Act of 2021 S. 234 (IS) - Americans Giving Care to Elders (AGE) Act of 2021 H.R. 8472 - Impact Aid Coronavirus Relief Act H.R.8075 - Impact Aid Coronavirus Relief Act S.4063 - Impact Aid Coronavirus Relief Act H.R.6800 - The HEROES Act S. 4800 - The HEROES Act H.R.133 - Consolidated Appropriations Act, 2021 H.R.8319 - Continuing Appropriations Act, 2021 H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act S.3370 - Coronavirus Vaccine Act
Client expense: Not reported · Firm income: $30,000
2021 · first_quarter · Real Estate/Land Use/Conservation
Specific Lobbying Issues: 1031 Like Kind Exemption Coalition - U.S. House and Senate American Rescue Act Covid Provisions/RIDEA - U.S. House and Senate HHS Provider Fund relief - U.S. House, Senate, Health and Human Services Health Real Estate Investment Trusts (REIT) provisions - U.S. House COVID-19 provisions - White House Bills: H.R.748 - Coronavirus Aid, Relief, and Economic (CARES) Act H.R.335 - American Rescue Plan H.R.6351 - Universal Coronavirus Vaccine Act S.3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.1319 - American Rescue Plan Act of 2021 H.R. 8805 - Retail Revitalization Act of 2020 H.R. 840 - Retail Revitalization Act of 2021 S. 234 (IS) - Americans Giving Care to Elders (AGE) Act of 2021 H.R. 8472 - Impact Aid Coronavirus Relief Act H.R.8075 - Impact Aid Coronavirus Relief Act S.4063 - Impact Aid Coronavirus Relief Act H.R.6800 - The HEROES Act S. 4800 - The HEROES Act H.R.133 - Consolidated Appropriations Act, 2021 H.R.8319 - Continuing Appropriations Act, 2021 H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act S.3370 - Coronavirus Vaccine Act
Client expense: Not reported · Firm income: $30,000
| Republican |
| FL |
| Mike Lee | Republican | UT |
| Thom Tillis | Republican | NC |
| Tommy Tuberville | Republican | AL |
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office